| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/01/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 5k | $34.11 | $170.6k | | 06/01/2023 |
| 06/01/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 5k | $86.00 | $430k | | 06/01/2023 |
| 04/03/2023 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 5k | $34.11 | $170.6k | | 04/03/2023 |
| 04/03/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 5k | $75.00 | $375k | | 04/03/2023 |
| 02/23/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.1k | $68.76 | $75.9k | | 02/23/2023 |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 6.6k | $0.00 | $0 | | 02/21/2023 |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 553 | $58.50 | $32.4k | | 02/21/2023 |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 9.4k | $35.46 | $333.4k | | 02/21/2023 |
| 01/27/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 367 | $52.77 | $19.4k | | 01/27/2023 |
| 01/23/2023 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 3k | $51.58 | $152.4k | | 01/23/2023 |
| 01/20/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 1.4k | $52.05 | $73.4k | | 01/20/2023 |
| 01/28/2022 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 434 | $38.59 | $16.7k | | 01/28/2022 |
| 01/21/2022 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 24.8k | $35.46 | $878.5k | | 01/21/2022 |
| 01/21/2022 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 17.5k | $0.00 | $0 | | 01/21/2022 |
| 01/28/2021 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 5k | $0.00 | $0 | | 01/28/2021 |
| 01/28/2021 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 1.2k | $0.00 | $0 | | 01/28/2021 |
| 01/28/2021 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 30k | $44.90 | $1.3M | | 01/28/2021 |
| 01/28/2021 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 7.5k | $44.90 | $336.8k | | 01/28/2021 |